Frequency Therapeutics, Inc.·4

Jan 27, 4:38 PM ET

McCubbin Quentin 4

4 · Frequency Therapeutics, Inc. · Filed Jan 27, 2023

Insider Transaction Report

Form 4
Period: 2023-01-26
McCubbin Quentin
Chief Manufacturing Officer
Transactions
  • Award

    Restricted Stock Unit

    2023-01-26+105,000105,000 total
    Common Stock (105,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
  • [F2]The restricted stock units will vest in four equal annual installments beginning on January 26, 2024.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT